References
- Nicosia, R.F. (1998) Am. J. Pathol. 153, 11– 16.
- Unger, C. (1997) Drugs Future 22, 1337– 1345.
- Sorbera, L.A., Castaner, R.M. and Leeson, P.A. (2000) Drugs Future 25, 551– 557.
- Mendel, D.B., Laird, A.D., Smolich, B.D., Blake, R.A., Liang, C., Hannah, A.L., Shaheen, R.M., Ellis, L.M., Weitman, S., Shawver, L.K. and Cherrington, J.M. (2000) Anti-Cancer Drug Des. 15, 29 – 41.
- Braud, E., Duflos, M., Nourrisson, M.R., Tonnerre, A., Picot, C., Le Baut, G., Renard, P., Pfeiffer, B. and Tucker, G. (2003) J. Enz. Inhib. Med. Chem. 18, 243– 252.
- Kadin, S.B. (1972) J. Med. Chem. 15, 551– 552.
- Sun, L., Tran, N., Tang, F., App, H., Hirth, P., McMahon, G. and Tang, C. (1998) J. Med. Chem. 41, 2588– 2603.
- Nicosia, R.F. and Ottinetti, A. (1990) Lab. Invest. 63, 115 – 122. [9] Montesano, R., Orci, L. and Vassalli, P. (1983) J. <i>Cell Biol. 97, 1648– 1652.
- Knedler, A. and Ham, R.G. (1987) In Vitro Cell Dev. Biol. 23, 481– 491.
- Walter, R. and Zimmer, H. (1964) J. Heterocyclic Chem. 1, 205– 206.
- Walter, R., Zimmer, H. and Purcell, T.C. (1966) J. Org. Chem. 31, 3854– 3857.
- Takeuchi, Y., Choshi, T., Tomozane, H., Yoshida, H. and Yamato, M. (1990) Chem. Pharm. Bull. 38, 2265– 2267.
- Nicolaides, D.N., Adamopoulos, S.G., Lefkaditis, D.A., Litinas, K.E. and Tarantili, P.V. (1992) J. Chem. Soc., Perkin Trans. 1, 283– 289.
- Litinas, K.E. and Stampelos, X.N. (1992) J. Chem. Soc., Perkin Trans. 1, 2981– 2984.
- Gripenberg, J. and Juselius, B. (1954) Acta. Chem. Scand. 8, 734– 737.
- Molho, D. and Coillard, J. (1956) Bull. Soc. Chim. Fr., 78 – 93. [18] Levine, J., Eble, T.E. and Fischbach, H. (1948) J. Am. <i>Chem. Soc. 60, 1930.
- Czaplicki, S. and Kostanecki, St.V. (1909) Chem. Ber. 42, 827 – 838.
- Kingsbury, C.A., Draney, D., Sopchik, A., Rissler, W. and Durham, D. (1976) J. Org. Chem. 41, 3863– 3868.
- Letcher, R.M. and Ng, K.W. (1989) J. Chem. Res. (S), 198 – 199.